HCW Biologics Inc. (HCWB)
NASDAQ: HCWB · Real-Time Price · USD
5.26
+4.23 (410.29%)
Jun 29, 2026, 4:00 PM EDT - Market closed
HCW Biologics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 6.59 | 0.05 | 2.57 | 2.84 | 6.72 | - | |
Revenue Growth (YoY) | 356.16% | -97.89% | -9.68% | -57.73% | - | - |
Cost of Revenue | 0.05 | 0.04 | 1.61 | 2.28 | 4.14 | - |
Gross Profit | 6.54 | 0.01 | 0.96 | 0.56 | 2.59 | - |
Selling, General & Admin | 7.6 | 6.23 | 22.73 | 13.35 | 8.33 | 5.19 |
Research & Development | 5.22 | 5.44 | 6.39 | 7.68 | 9.34 | 8.17 |
Other Operating Expenses | 0.2 | 1.5 | 1.3 | 5.25 | - | - |
Total Operating Expenses | 13.02 | 13.17 | 30.42 | 26.28 | 17.67 | 13.37 |
Operating Income | -7.98 | -13.16 | -29.46 | -25.72 | -15.08 | -13.37 |
Interest Expense | -0.68 | -0.85 | -0.65 | -0.28 | -0.13 | - |
Other Non-Operating Income (Expense) | 1.5 | 6.05 | 0.09 | 1.01 | 0.3 | 0.51 |
Total Non-Operating Income (Expense) | 0.83 | 5.2 | -0.57 | 0.72 | 0.18 | 0.51 |
Pretax Income | 3.8 | -7.96 | -30.02 | -24.99 | -14.9 | -12.86 |
Provision for Income Taxes | 0.33 | - | - | - | - | - |
Net Income | -2.29 | -7.96 | -30.02 | -24.99 | -14.9 | -12.86 |
Net Income Attributable to Preferred Dividends | -15.83 | -14.34 | - | - | - | - |
Net Income to Common | -18.12 | -22.3 | -30.02 | -24.99 | -14.9 | -12.86 |
Shares Outstanding (Basic) | 3 | 2 | 1 | 1 | 1 | 0 |
Shares Outstanding (Diluted) | 3 | 2 | 1 | 1 | 1 | 0 |
Shares Change (YoY) | 216.07% | 116.30% | 7.97% | 0.30% | 90.84% | 296.07% |
EPS (Basic) | -9.46 | -10.63 | -30.96 | -28.00 | -16.80 | -27.60 |
EPS (Diluted) | -9.46 | -10.63 | -30.96 | -28.00 | -16.80 | -27.60 |
Free Cash Flow | -11.45 | -13.39 | -14.49 | -28.72 | -20.66 | -11.02 |
Free Cash Flow Per Share | -3.57 | -6.38 | -14.94 | -31.97 | -23.07 | -23.49 |
Gross Margin | 99.24% | 20.00% | 37.38% | 19.72% | 38.48% | - |
Operating Margin | -121.09% | -24270.70% | -1147.60% | -904.96% | -224.32% | - |
Profit Margin | -34.74% | -14677.10% | -1169.70% | -879.52% | -221.67% | - |
FCF Margin | -173.74% | -24693.20% | -564.48% | -1010.51% | -307.36% | - |
EBITDA | -7.22 | -12.12 | -28.27 | -24.58 | -14.36 | -12.82 |
EBITDA Margin | -109.49% | -22349.80% | -1101.46% | -865.02% | -213.64% | - |
EBIT | -7.98 | -13.16 | -29.46 | -25.72 | -15.08 | -13.37 |
EBIT Margin | -121.09% | -24270.70% | -1147.60% | -904.96% | -224.32% | - |
Effective Tax Rate | 8.68% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |